title: Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III.
abstract: OBJECTIVE
  Elevated levels of serum carcinoembryonic antigen (CEA) following a curative resection of colorectal cancer (CRC) indicate recurrence; however, the levels of CEA may be elevated above the normal limit without recurrence. The aim of this study is to analyze the diagnostic accuracy of elevated serum CEA for predicting recurrence in postoperative stage II and stage III CRC patients.
  
  
  METHODS
  A total of 336 stage II and stage III CRC patients who underwent a curative resection between January 2005 and October 2009 were enrolled. Sensitivities, specificities, positive predictive values (PPVs), negative predictive values (NPVs), likelihood ratios and post-test probabilities of recurrence associated with elevated CEA were analyzed and compared.
  
  
  RESULTS
  The median follow-up duration was 45 months (36 to 134 months). Twenty-seven of 189 stage II patients (14.3%) and 52 of 147 stage III patients (35.4%) developed recurrence during the follow-up period. Sensitivities, specificities, PPVs, and NPVs of elevated CEA were 37.0%, 91.4%, 41.7%, and 89.7%, respectively, in stage II patients and 46.2%, 90.5%, 72.7%, and 75.4% in stage III patients. Post-test probabilities of recurrence associated with elevated CEA were 41.8% in stage II patients and 71.9% in stage III patients.
  
  
  CONCLUSIONS
  The predictive performance of the probability of recurrence associated with elevated serum CEA after a curative resection in stage II CRC patients is lower than that in stage III CRC patients.
authors.affiliation: Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea.
authors.forename: Ho Seung
authors.initials: HS
authors.lastname: Kim
authors.forename: Min Ro
authors.initials: MR
authors.lastname: Lee
keywords: Accuracy; Carcinoembryonic antigen; Colorectal neoplasms; Recurrence; Tumor marker
references.citation: J Clin Oncol. 2006 Nov 20;24(33):5313-27
references.pmid: 17060676
references.citation: JAMA. 1982 May 14;247(18):2543-6
references.pmid: 7069920
references.citation: Cancer Invest. 2005;23(4):338-51
references.pmid: 16100946
references.citation: Ann Surg Oncol. 2007 Feb;14(2):417-23
references.pmid: 17103264
references.citation: Ann Oncol. 2005 May;16(5):756-61
references.pmid: 15790673
references.citation: World J Gastroenterol. 2006 Jun 28;12(24):3891-4
references.pmid: 16804977
references.citation: Surg Today. 2011 Oct;41(10):1357-62
references.pmid: 21922357
references.citation: Br J Cancer. 1994 Sep;70(3):549-53
references.pmid: 8080745
references.citation: World J Surg. 2005 May;29(5):561-6
references.pmid: 15827842
references.citation: Am Surg. 2010 Oct;76(10):1100-3
references.pmid: 21105619
references.citation: Dis Colon Rectum. 2008 Nov;51(11):1675-80
references.pmid: 18633674
references.citation: Int J Colorectal Dis. 1999 Feb;14(1):73-7
references.pmid: 10207736
references.citation: Eur Surg Res. 2007;39(4):245-50
references.pmid: 17457032
references.citation: Tumour Biol. 1994;15(1):1-6
references.pmid: 8146525
references.citation: J Surg Oncol. 2010 Aug 1;102(2):154-7
references.pmid: 20648586
references.citation: Aust J Physiother. 2002;48(3):227-32
references.pmid: 12217073
references.citation: Dis Colon Rectum. 1991 Sep;34(9):794-7
references.pmid: 1914746
references.citation: Acta Paediatr. 2007 Apr;96(4):487-91
references.pmid: 17306009